Asarch KE, Ransom RW, Shih JS (1985) 5-HT_1A and 5-HT_1B selectivity of two phenylpiperazine derivatives: evidence for 5-HT1_B heterogeneity. Life Sci 36:1265–1273

Article  PubMed  CAS  Google Scholar 

Baxter MJ, Miller AA, Soroko FE (1970) The effect of cyproheptadine on food consumption in the fasted rat. Br J Pharmacol 39:229–230

Google Scholar 

Bergen SS (1964) Appetite stimulating properties of cyproheptadime. Am J Dis Child 108:270–273

PubMed  Google Scholar 

Clineschmidt BV, Flataker LM, Faison E, Holmes R (1979) An in vivo model for investigation α₁ and α₂-receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn 242:59–76

PubMed  CAS  Google Scholar 

Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1C) receptors. J Pharmacol Exp Ther 242:552–557

PubMed  CAS  Google Scholar 

Closse A (1983) [³H] mesulergine, a selective ligand for serotonin-2 receptors. Life Sci 32:2485–2495

Article  PubMed  CAS  Google Scholar 

Dickinson SL, Gadie B, Tulloch IF (1987) Preclinical in vivo assessment of α₂ adrenergic activity in the central nervous system. Proc 1st Int Symp on Preclin Strategies in Psychopharmacol, Paris, p 6

Dourish CT, Hutson PH, Curzon G (1985) Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Brain Res Bull 15:377–384

Article  PubMed  CAS  Google Scholar 

Dourish CT, Hutson PH, Kennett GA, Curzon G (1986) 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite [Suppl] 7:127–140

PubMed  CAS  Google Scholar 

Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT_1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7

Article  CAS  Google Scholar 

Ferguson JJ, Feighner JP (1987) Fluoxetine induced weight loss in non-depressed overweight humans. Am J Psychiatry 143:1496

Google Scholar 

Fuller RW, Mason NR, Snoddy HD, Perry KW (1986) 1-(1-naphthyl)piperazine, a central serotonin agonist. Res Commun Chem Pathol Pharmacol 51:37–45

PubMed  CAS  Google Scholar 

Ghosh MN, Parvathy S (1973) The effect of cyproheptadine on water and food intake and on body weight in the fasted adult and weanling rats. Br J Pharmacol 48:328–329

Google Scholar 

Goudie AJ, Thornton EW, Wheeler TJ (1978) Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for a serotonergic inhibition of feeding. J Pharm Pharmacol 28:318–320

Google Scholar 

Green AR, Guy AP, Gardner CR (1984) The behavioural effects of RU 24969, a suggested 5-HT, receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants. Neuropharmacology 23:655–661

Article  PubMed  CAS  Google Scholar 

Hamon M, Cossery J-M, Spampinato U, Gozlan H (1986) Are there selective ligands for 5-HT_1A and 5-HT_1B receptor binding sites in brain? TIPS 7:336–337

CAS  Google Scholar 

Harris B, Harper M (1980) Unusual appetites in patients on mianserin. Lancet I:590

Article  Google Scholar 

Heuring RE, Peroutka SJ (1987) Charaterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–903

PubMed  CAS  Google Scholar 

Hopman H (1980) Mianserin in out patients with depressive illness in dosage up to 130 mg daily. Curr Med Res Opin [Suppl 7] 6:107–114

Google Scholar 

Hoyer D (1988) Biochemical mechanisms of 5-HT receptor effector coupling in peripheral tissues. In: Fozard J (ed) Peripheral actions of 5-HT. Oxford University Press (in press)

Hoyer D, Engel G, Kackman HO (1985) Molecular pharmacology of 5-HT₁ and 5-HT₂ recognition sites in rat and pig brain membranes: radioligand binding studies with [³H] 5-HT, [³H] 8-OH-DPAT, (−) [¹²⁵I] iodocyanopindolol, [³H] mesulergine and [³H] ketanserin. Eur J Pharmacol 118:13–23

Article  PubMed  CAS  Google Scholar 

Hutson PH, Donohoe TP, Curzon G (1988) Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95:550–552

Article  PubMed  CAS  Google Scholar 

Hutson PH, Dourish CT, Curzon G (1986) Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by cell body autorcceptors. Eur J Pharmacol 129:347–352

Article  PubMed  CAS  Google Scholar 

Invernizzi R, Cotecchia S, De Blasi A, Mennini T, Pataccini R, Samanin R (1981) Effects ofm-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. Neurochem Int 3:239–244

Article  CAS  Google Scholar 

Kennett GA, Curzon G (1988) Evidence thatmCPP may have behavioural effects mediated by 5-HT_1C receptors. Br J Pharmacol 94:137–147

PubMed  CAS  Google Scholar 

Kennett GA, Dourish CT, Curzon G (1987) 5-HT_1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol 141:429–435

Article  PubMed  CAS  Google Scholar 

Kilpatrick GJ, Jones BJ, Tyers MB (1988) Identification and distribution of 5-HT₃ receptors in rat brain using radioligand binding. Nature 330:746–748

Article  Google Scholar 

Lavenstein AF, Lasagna L, Van Metre TE (1962) Effect of cyproheptadine on asthmatic children, study of appetite, weight gain and linear growth. JAMA 180:912–916

PubMed  CAS  Google Scholar 

Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R41 468, a novel antagonist of 5-HT2 receptors. Life Sci 28:1015–1022

Article  PubMed  CAS  Google Scholar 

Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PAJ, Laduron PM (1985) Receptor binding properties in vitro and in vivo of ritanserin, a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611

PubMed  CAS  Google Scholar 

Lucki I, Frazer A (1982) Behavioural effects of indole and piperazine type serotonin receptor agonists. Soc Neurosci Abst 8:101

Google Scholar 

Menon MK, Clark WG, Aures D (1971) Effect of Thiazol-4-xylmethoxyamine, a new inhibitor of histamine biosynthesis on brain histamine, monoamine levels and behaviour. Life Sci 10:1097–1109

Article  CAS  Google Scholar 

Peng Y, Tews JK, Harper AE (1972) Amino acid imbalance, protein intake, and changes in rat brain and plasma amino acids. Am J Physiol 222:314–321

PubMed  CAS  Google Scholar 

Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10:241–323

PubMed  CAS  Google Scholar 

Pinder RM, Blum A, Stulemeijer SM, Barres M, Molczadzki M, Rigand A, Charbaut J, Israel L, Kammerer T (1980) A double-blind multi-centre trial comparing the efficacy and side effects of mianserin and clomipramine is depressed in-patients and out patients. Curr Med Res Opin [Suppl 7] 6:115–122

Google Scholar 

Richardson BP, Engel S, Donatsch P, Stadler PA (1985) Identification of serotoninm-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131

Article  PubMed  CAS  Google Scholar 

Rowland NC, Carlton J (1986) Neurobiology of an anorexic drug fenfluramine. Prog Neurobiol 27:13–62

Article  PubMed  CAS  Google Scholar 

Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979)m-chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 308:159–163

Article  CAS  Google Scholar 

Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and non-selective compounds for the 5-HT_1A and 5-HT_1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487

PubMed  CAS  Google Scholar 

Smith TM, Suckow RF (1985) Trazodone andm-chlorophenylpiperazine; concentration in brain and receptor activity in regions in the brain associated with anxiety. Neuropharmacology 24:1067–1071

Article  PubMed  CAS  Google Scholar 

Tricklebank MD, Middlemiss DN, Neill J (1986) Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT₁ receptor agonist RU 24969 in the rat. Neuropharmacology 25:877–886

Article  PubMed  CAS  Google Scholar